![Canadians living with Moderate to Severe Hidradenitis Suppurativa are beginning to have public access to HUMIRA® (Adalimumab) to manage their disease | Markets Insider Canadians living with Moderate to Severe Hidradenitis Suppurativa are beginning to have public access to HUMIRA® (Adalimumab) to manage their disease | Markets Insider](https://mma.prnewswire.com/media/644330/AbbVie_Canada_Canadians_living_with_Moderate_to_Severe_Hidradeni.jpg)
Canadians living with Moderate to Severe Hidradenitis Suppurativa are beginning to have public access to HUMIRA® (Adalimumab) to manage their disease | Markets Insider
![AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/2016-09/humiragood.jpg?VersionId=IMHQKeP3FEsbi1KzkE2Lmb6oS2BKDhtf)
AbbVie's Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care | Fierce Pharma
![Costs for lifesaving drugs have skyrocketed. Experts say 'over-patenting' to prevent generic competition is part of the problem. Costs for lifesaving drugs have skyrocketed. Experts say 'over-patenting' to prevent generic competition is part of the problem.](https://www.philly.com/resizer/tfPHo68eP3erDTjDw3zDiRd-3ZY=/arc-anglerfish-arc2-prod-pmn/public/JDKQHQLMEFFDHJBQMHXSIFKJSA.jpg)